Croda International PLC Trading update (2354C)
09 Giugno 2023 - 8:00AM
UK Regulatory
TIDMCRDA
RNS Number : 2354C
Croda International PLC
09 June 2023
9 June 2023
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) No 596/2014 (as it
forms part of Retained EU Law as defined in the European Union
(Withdrawal) Act 2018).
Croda International Plc
Trading update
Croda International Plc ('Croda' or 'the Group') today provides
an update on trading for the period ending 31 May 2023.
In Consumer Care, whilst sales volumes are up compared to the
final quarter of 2022, they remain down double-digit percentage
compared with the same period last year as a result of customer
destocking continuing through the second quarter. Price increases
implemented in 2022 and favourable foreign exchange rates so far in
2023 have helped to offset this impact, with revenues broadly flat
versus the first five months of 2022. However, principally due to
the lower sales volumes, operating profit margin has remained at a
similar level to the second half of 2022.
In Life Sciences, Crop Protection started the year well, but the
business is now experiencing rapid customer destocking, which was a
factor originally expected to materialise more gradually later in
the year. Life Sciences' operating profit margin is being
negatively impacted by adverse mix in the year to date including
lower sales for Covid-19 applications in the Pharma business.
Shipments of lipid systems to our principal Covid vaccine customers
are expected to occur as planned in the second half of 2023.
As a result of these factors, the Group generated GBP143m profit
before tax in the first five months of the year, supported by
minimal net finance costs. With customer destocking in consumer and
industrial end-markets now expected to continue into the second
half year and momentum moderating in Crop Protection, full year
2023 Group profit before tax is now expected to be between GBP370m
and GBP400m.
Croda will report half year results for the six months to 30
June on 25 July 2023.
The person responsible for making this announcement is Louisa
Burdett, Chief Financial Officer.
Further information:
There will be a conference call for covering analysts at 0800
BST this morning with dial-in details below. Participants are
encouraged to dial in early as they will need to register with the
moderator.
-- Operator Assisted Dial-In:
-- United Kingdom (Local): +44 20 3936 2999
-- United Kingdom (Toll-Free): +44 800 358 1035
-- Global Dial-In Numbers
-- Access Code: 360297
For enquiries contact:
Investors: David Bishop, Croda +44 7823 874428
Press: Charlie Armitstead, Teneo +44 7703 330269
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTSSISLUEDSEFM
(END) Dow Jones Newswires
June 09, 2023 02:00 ET (06:00 GMT)
Grafico Azioni Croda (LSE:CRDA)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Croda (LSE:CRDA)
Storico
Da Mag 2023 a Mag 2024